Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges of nucleic acid vaccine delivery, today announced that its Tropis ® System ...

The nucleic acid delivery market is maturing with over 1,450 clinical trials underway worldwide. The majority of these are in early clinical development (approximately 60%) with just over 3% in ...

Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach. Biomacromolecules , 2024; DOI: 10.1021/acs ...

Two Antibody-Guided Lactic-co-Glycolic Acid-Polyethylenimine (LGA-PEI) Nanoparticle Delivery Systems for Therapeutic Nucleic Acids. Pharmaceuticals , 2021; 14 (9): 841 DOI: 10.3390/ph14090841 Cite ...

This article highlights the current state of macromolecular gene delivery systems, their applications, and the ongoing ...

Study: Nucleic acid delivery and nanoparticle design for COVID vaccines. Image Credit: Love Employee / Shutterstock.com. Introduction. Nucleic acid therapeutics can harness the potential of ...

Eli Lilly and Company has acquired exclusive rights to Entos Pharmaceuticals’ nucleic acid delivery technology for $50 million. As part of the deal, Entos will create proteolipid vehicles for ...

Researchers trace the 60-year evolution of lipid nanoparticles (LNPs) for nucleic acid delivery, highlighting their potential to revolutionize gene therapy with safer and more effective treatments.

Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work By Nick Paul Taylor Jan 24, 2023 6:30am AstraZeneca University of Oxford anti-sense oligo messenger RNA ...

Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach. Article Publication Date. 26-Aug-2024.